Growth Metrics

Amneal Pharmaceuticals (AMRX) Current Taxes (2018 - 2019)

Amneal Pharmaceuticals has reported Current Taxes over the past 2 years, most recently at $8.7 million for Q4 2019.

  • For Q4 2019, Current Taxes rose 653.15% year-over-year to $8.7 million; the TTM value through Dec 2019 reached $8.7 million, up 653.15%, while the annual FY2019 figure was $8.7 million, 653.15% up from the prior year.
  • Current Taxes for Q4 2019 was $8.7 million at Amneal Pharmaceuticals, up from $1.2 million in the prior quarter.
  • Over five years, Current Taxes peaked at $8.7 million in Q4 2019 and troughed at $1.2 million in Q4 2018.